FDG levels show link between Alzheimer's, Down syndrome
July 29, 2020 -- PET imaging has revealed reduced FDG uptake in key brain regions associated with early- and late-stage Alzheimer's disease among people with Down syndrome. The findings could indicate the degree of brain atrophy in individuals, as well as one reason why this patient population is susceptible to dementia.  Discuss
Radiomics can predict treatment outcome for NSCLC
July 27, 2020 -- Radiomics features on pretreatment FDG-PET exams can foretell outcomes in patients with non-small cell lung cancer (NSCLC), according to research presented at the 2020 virtual annual meeting of the Society of Nuclear Medicine and Molecular Imaging.  Discuss
Molecular imaging mourns death of Stanford's Gambhir
July 20, 2020 -- The molecular imaging and radiology communities are mourning the death of Dr. Sanjiv Sam Gambhir, PhD, the chair of radiology at Stanford University, who died of cancer on July 18. He was 57.  Discuss
SNMMI 2020: AI analysis of PET could help classify prostate cancer
July 17, 2020 -- An artificial intelligence (AI) algorithm may be able to assist in classifying prostate lesions on 3D prostate-specific membrane antigen-PET exams, according to research presented at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).  Discuss
SNMMI 2020: Researchers develop novel prostate cancer agents
July 16, 2020 -- Research on prostate cancer imaging agents that can be produced faster and cheaper than current radiotracers -- and also have therapeutic potential -- was presented by a group from Memorial Sloan Kettering Cancer Center at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 virtual annual meeting.  Discuss
SNMMI 2020: PET tracer could image, treat glioblastoma
July 15, 2020 -- A new, relatively long-lived PET tracer can safely and effectively image patients with glioblastoma, according to research presented at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). The tracer also shows potential as a radiotheragnostic agent.  Discuss
SNMMI 2020: PET/MRI finds location of chronic pain in patients
July 15, 2020 -- An imaging technique that combines F-18 FDG PET and MRI was able to pinpoint the origins of chronic pain in patients and help their caregivers develop better management plans, according to a Monday presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 virtual annual meeting.  Discuss
SNMMI 2020: PSMA-PET/CT changes prostate cancer management
July 15, 2020 -- PET/CT imaging with an F-18 DCFPyL prostate-specific membrane antigen (PSMA) radiopharmaceutical changed prostate cancer management in two-thirds of cases, according to research presented July 13 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 virtual annual meeting.  Discuss
SNMMI 2020: PET radiotracer measures stroke recovery
July 15, 2020 -- A new PET radiotracer may one day help clinicians evaluate stroke recovery, according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 virtual annual meeting. Researchers used the radiotracer, F-18 SynVesT-2, to assess synaptic density in rat brains.  Discuss
SNMMI 2020: Image of the Year scans reveal 'super-agers'
July 14, 2020 -- A group of German researchers has received the Image of the Year award from the Society of Nuclear Medicine and Molecular Imaging (SNMMI) for a series of PET images that show that older adults who maintained peak cognitive skills exhibited greater resistance to buildup of tau and amyloid proteins.  Discuss